2022 研究論文

 

篇序

作者(順位)

論文題目

發表雜誌名稱(含年月/卷期/頁次)

1

何聖佑(1)

Retrospective Analysis Of Adjuvant Radiotherapy In Oral Cavity Or Oropharyngeal Cancer: Feasibility Of Omitting Lower-Neck Irradiation

PLOS ONE(SCI)
Vol 17/NO 4/P E0266-2022

2

何聖佑(C)

Perihippocampal Failure After Hippocampalavoidance Whole-Brain Radiotherapy In Cancer Patients With Brain Metastases-Results Of A Retrospective Analysis

J formos med assoc(SCI)
Vol 101/NO 14/P e29144, 2022

3

何聖佑(1)

Mechanisms Of Nanotoxicology And The Important Role Of Alternative Testing Strategies

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(SCI)
Vol 23/NO /P 8204-, 2022

4

何聖佑(C)

Retrospective Analysis Of Dosimetry On Hippocampal-Avoidance Whole-Brain Radiotherapy In A Regional Hospital

THERAPEUTIC RADIOLOGY AND ONCOLOGY
Vol 22/NO 17/P -, 2022

5

何聖佑(2)

Treatment Outcomes Of Primary Surgery Versus Chemoradiotherapy For T4 Oropharyngeal Cancers

MEDICINE(SCI)
Vol 101/NO 48/P E3198-2022

6

何聖佑(1)

Mechanisms Of Nanotoxicology And The Important Role Of Alternative Testing Strategies

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES(SCI)
Vol 23/NO 15/P 8204-2022

7

何聖佑(C)

Metachronous Intramedullary Anaplastic Astrocytoma And Liposarcoma Complicating With Neurofibromatosis Type 1: A Case Report And Analysis Of Family History

JOURNAL OF MEDICAL SCIENCES
Vol /NO /P -2022

8

何聖佑(C)

Comparison Of Healthcare Utilization And Life-Sustaining Interventions Between Patients With Glioblastoma Receiving Palliative Care Or Not: A Population-Based Study

PALLIATIVE MED(SCI)
Vol /NO /P -2023

9

楊清傑(2)

 Formin-Like 2 Is a Potential Biomarker of Poor Prognosis in  Nasopharyngeal Carcinoma

Oncology(SCI) 
100:475–484, 2022

10

楊清傑(2)

Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma

Clinical Medicine Insights: Oncology Volume(SCI)
16: 1–82022

11

楊清傑(C)洪瑋汝(1)

The Effect Of Adjuvant Radiotherapy On Clinical Outcomes In Early Major Salivary Gland Cancer

HEAD NECK-J SCI SPEC(SCI)
Vol /NO /P -, 2022

12

楊清傑(3)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients

Pathol Oncol Res.(SCI)
6;28:162022 Oct

13

楊清傑(5)

Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy

OncoTargets and Therapy(SCI)
:15 1171–11812022

14

楊清傑(C)

High Expression Of Folate Receptor Alpha (Folr1) Is Associated With Aggressive Tumor Behavior, Poor Response To Chemoradiotherapy, And Worse Survival In Rectal Cancery

TECHNOL CANCER REST(SCI)
Vol 21/NO /P 1-7, 2022

15

楊清傑(C)

No Survival Benefit From Adding Chemotherapy To Adjuvant Radiation In Advanced Major Salivary Gland Cancer

REP-UK(SCI)
Vol 12/NO /P -, 2022

16

楊清傑(C)

Adjuvant Chemotherapy And Survival Outcomes In Rectal Cancer Patients With Good Response (Ypt0-2n0)After Neoadjuvant Chemoradiotherapy And Surgery: A Retrospective Nationwide Analysis

FRONT ONCOL(SCI)
Vol 12/NO /P 1087778, 2022

17

楊清傑(2)

Obesity Mediated Upregulation Of Theyap/IL33 Signaling Axis Promotes Aggressiveness And Induces An Immunosuppressive Tumor Microenvironment In Breast Cancer

J CELL PHYSIOL(SCI)
Vol /NO /P -2023

18

楊清傑(4)

REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT

Histology and Histopathology (Accepted)-SCI